文献速递外周动脉疾病

孤立性股深动脉闭塞性病变腔内治疗的结果

Outcomes of Endovascular Management of Isolated Profunda Femoris Artery Occlusive Disease.
PubMed 文献 · Ann Vasc Surg · 2020-09-28

基于血管质量倡议(VQI)2013至2018年数据的回顾性分析,纳入341例因孤立性股深动脉闭塞性病变接受腔内治疗的361次手术,占同期下肢腔内干预的0.3%。平均随访13个月,总体一期通畅率为92.9%,症状改善率67%,再干预率15.8%,各治疗方式间通畅率无显著差异。

要点

  • 孤立性股深动脉腔内治疗占下肢腔内干预的0.3%,最常见指征为间歇性跛行(44.8%)。
  • 13个月总体一期通畅率92.9%,各治疗方式间无显著差异。
  • 再干预率15.8%,多数再干预(62%)发生在普通球囊组。

核心结论

  • 孤立性股深动脉闭塞性病变腔内治疗具有可接受的一年通畅率和较低的再干预率。
  • 腔内治疗可能是手术高风险的选择性患者的可接受替代方案。

研究设计与样本

  • 回顾性分析,使用血管质量倡议(VQI)2013至2018年数据。
  • 纳入341例患者共361次因孤立性股深动脉闭塞性病变接受的腔内手术。
  • 平均年龄67.8岁(±11.8),男性占59.8%。

主要发现

  • 手术占同期105568次下肢腔内干预的0.3%。
  • 治疗指征:间歇性跛行44.8%,组织缺损28.5%,静息痛26.0%。
  • 治疗方式:普通球囊58.5%,支架18.6%,药物涂层球囊10.0%,斑块旋切9.4%,覆膜支架3.6%。
  • 平均随访13个月(±4.6),238例(69.7%)有随访数据,总体一期通畅率92.9%。
  • 各治疗方式间通畅率无显著差异;术前行走状态、阿司匹林和他汀与通畅率显著相关。

关键数值与推荐

  • 最近随访时67%患者症状改善,29%无变化。
  • 247例有再干预数据,再干预率15.8%(n=39),平均再干预时间226天(±173)。
  • 再干预多数为腔内(64%),9例(23%)接受外科再干预。

临床怎么用

  • 对于手术高风险的孤立性股深动脉闭塞性病变患者,腔内治疗可作为可接受的替代选择。
  • 普通球囊是最常用方式,但再干预多集中于此组,需注意随访。
  • 术前行走状态、阿司匹林和他汀使用与通畅率相关,围术期应关注。

局限性

  • 回顾性分析,存在选择偏倚。
  • 随访数据仅覆盖69.7%的患者,可能存在失访偏倚。
  • 平均随访仅13个月,缺乏长期结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular management of isolated profunda femoris artery occlusive disease has not been well studied. Our aim is to analyze the outcomes of endovascular management of profunda artery occlusive disease. METHODS: This is a retrospective analysis using data from the Vascular Quality Initiative. All patients from 2013 to 2018 treated percutaneously for isolated profunda artery occlusive disease were included. Endovascular treatment included plain balloon alone, stent, stent graft, atherectomy, and drug-coated balloon without any concomitant endovascular or surgical treatment. Demographic, procedural, and follow-up data were obtained. Primary end points were primary patency, improvement of symptoms, and need for reintervention. Univariate and multivariable analysis was used to assess for significant variables. RESULTS: Of the 105,568 lower extremity endovascular interventions performed during this time period, there were 361 procedures (0.3%) performed on 341 patients for isolated profunda artery occlusive disease. The average age of these patients was 67.8 years (+/- 11.8), with 59.8% being men. The most common indication for treatment of the profunda artery was claudication (44.8%), followed by tissue loss (28.5%) and rest pain (26.0%). The most common treatment modality was plain balloon (58.5%), followed by stent (18.6%), drug-coated balloon (10.0%), atherectomy (9.4%), and stent graft (3.6%). At a mean follow-up of 13 months (+/-4.6), data were available for 238 patients (69.7%). Overall primary patency at 13 months was 92.9%. There was no significant difference in terms of patency for each treatment modality (Table I). Preoperative ambulatory status, aspirin, and statin were significantly associated with patency. At most recent follow-up, 67% of patients had improvement of their symptoms, whereas 29% were unchanged. Reintervention data were available for 247 patients, with a reintervention rate of 15.8% (n = 39) and a mean reintervention time of 226 days (+/- 173), with the majority of reinterventions (62%) occurring in the plain balloon group. Reinterventions were primarily endovascular (64%) with 9 patients (23%) undergoing surgical reintervention. CONCLUSIONS: Endovascular management of profunda femoris artery occlusive disease has acceptable one-year patency rates with low reintervention rates. Endovascular treatment may be an acceptable alternative to selected patients who are high-risk for surgery.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Qato K, Nguyen N, Bouris V, et al. Outcomes of Endovascular Management of Isolated Profunda Femoris Artery Occlusive Disease. Ann Vasc Surg. 2020. PMID: 32991977. doi:10.1016/j.avsg.2020.08.138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。